The primary objective was to evaluate safety and tolerability of Ropanicant in patients with MDD
Wacker Biotech will manufacture the active ingredients of MinervaX’s novel vaccine candidate
At 10 years, more than one-third (34.0%) of patients with advanced melanoma were alive after treatment with KEYTRUDA, compared to 23.6% of patients treated with ipilimumab
Total investment incurred for setting up the new R&D Rs 250 crore
Lasa Supergenerics Limited has been granted patent for an invention “Processes for Preparation and Purification of 5-Chloro-2-Nitroaniline
The USFDA inspection focused on evaluating the facility's adherence to global regulatory requirements and best practices
GPCB has also asked to submit a bank guarantee of Rs. 2, 00,000 for compliance assurance at the time of revocation and has also ordered to deposit interim environment damage compensation amount
The acquisition is based on an enterprise value of Rs. 1,660 crore
This aims to benefit approximately 4.5 crore families with six crore senior citizens with Rs. 5 lakh free health insurance cover on a family basis
Increases efficiency by 70% compared to stainless steel or glass manufacturing methods
Subscribe To Our Newsletter & Stay Updated
